Molecular features and race‐associated outcomes of SPOP‐mutant metastatic castration‐resistant prostate cancer (Englisch)
- Neue Suche nach: Stangl, Andrew
- Neue Suche nach: Wilner, Christopher
- Neue Suche nach: Li, Pin
- Neue Suche nach: Maahs, Lucas
- Neue Suche nach: Hwang, Clara
- Neue Suche nach: Pilling, Amanda
- Neue Suche nach: Stangl, Andrew
- Neue Suche nach: Wilner, Christopher
- Neue Suche nach: Li, Pin
- Neue Suche nach: Maahs, Lucas
- Neue Suche nach: Hwang, Clara
- Neue Suche nach: Pilling, Amanda
In:
The Prostate
;
83
, 6
;
524-533
;
2023
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Molecular features and race‐associated outcomes of SPOP‐mutant metastatic castration‐resistant prostate cancer
-
Beteiligte:Stangl, Andrew ( Autor:in ) / Wilner, Christopher ( Autor:in ) / Li, Pin ( Autor:in ) / Maahs, Lucas ( Autor:in ) / Hwang, Clara ( Autor:in ) / Pilling, Amanda ( Autor:in )
-
Erschienen in:The Prostate ; 83, 6 ; 524-533
-
Verlag:
-
Erscheinungsdatum:01.05.2023
-
Format / Umfang:10 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 83, Ausgabe 6
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 487
-
Issue Information| 2023
- 489
-
Salvage stereotactic body radiation therapy for locally recurrent prostate cancer following primary radiation therapy, are benefits worth toxicity risks?: A systematic reviewBray, Gerard / Bahadori, Arya / Rama, Darren et al. | 2023
- 498
-
Low‐risk prostate lesions: An evidence review to inform discussion on losing the “cancer” labelSemsarian, Caitlin R. / Ma, Tara / Nickel, Brooke / Barratt, Alexandra / Varma, Murali / Delahunt, Brett / Millar, Jeremy / Parker, Lisa / Glasziou, Paul / Bell, Katy J. L. et al. | 2023
- 516
-
Utilization of genetic testing in men with advanced prostate cancerAguiar, Jonathan A. / Li, Eric V. / Siddiqui, Mohammad R. / Soliman, Moataz A. / Kumar, Sai K. S. R. / Schaeffer, Edward M. / Keeter, Mary Kate / Brown, C. Hendricks / Szymaniak, Brittany M. / Ross, Ashley E. et al. | 2023
- 524
-
Molecular features and race‐associated outcomes of SPOP‐mutant metastatic castration‐resistant prostate cancerStangl, Andrew / Wilner, Christopher / Li, Pin / Maahs, Lucas / Hwang, Clara / Pilling, Amanda et al. | 2023
- 534
-
Decursin inhibits EGFR‐ERK1/2 signaling axis in advanced human prostate carcinoma cellsBhat, Tariq A. / Dheeraj, Arpit / Nambiar, Dhanya K. / Singh, Surya Pratap / Yim, Dong Sool / Singh, Rana P. et al. | 2023
- 547
-
Lack of repeatability of radiomic features derived from PET scans: Results from a 18F‐DCFPyL test–retest cohortWerner, Rudolf A. / Habacha, Bilêl / Lütje, Susanne / Bundschuh, Lena / Kosmala, Alekandser / Essler, Markus / Derlin, Thorsten / Higuchi, Takahiro / Lapa, Constantin / Buck, Andreas K. et al. | 2023
- 555
-
Androgen deprivation therapy in men with prostate cancer is not associated with COVID‐19 infectionDavidsson, Sabina / Messing Eriksson, Anna / Udumyan, Ruzan / Swanholm, Per / Lewin Lundh, Maria / Widing, Carolina / Lindlöf, Christina / Fridfeldt, Jonna / Andersson, Sven‐Olof / Fall, Katja et al. | 2023
- 563
-
Docetaxel versus abiraterone for metastatic hormone‐sensitive prostate cancer with focus on efficacy of sequential therapyYanagisawa, Takafumi / Hata, Kenichi / Narita, Shintaro / Hatakeyama, Shingo / Mori, Keiichiro / Yata, Yuji / Sano, Takayuki / Otsuka, Takashi / Hara, Shuhei / Miyajima, Keiichiro et al. | 2023
- 572
-
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining‐targeted biopsyDiamand, Romain / Peltier, Alexandre / Roche, Jean‐Baptiste / Lievore, Elena / Lacetera, Vito / Chiacchio, Giuseppe / Beatrici, Valerio / Mastroianni, Riccardo / Simone, Giuseppe / Windisch, Olivier et al. | 2023
- 580
-
Detection of intraductal carcinoma in prostate cancer patients with small tumor volumeTakeshita, Nobushige / Sakamoto, Shinichi / Yamada, Yasutaka / Sazuka, Tomokazu / Imamura, Yusuke / Komiya, Akira / Akakura, Koichiro / Sato, Nobuo / Nakatsu, Hiroomi / Kato, Takuma et al. | 2023
- 590
-
Identification of androgen response‐related lncRNAs in prostate cancerKarthikeyan, Santhosh Kumar / Xu, Nuo / Ferguson 3<sup>rd</sup>, James E. / Rais‐Bahrami, Soroush / Qin, Zhaohui S. / Manne, Upender / Netto, George J. / S. Chandrashekar, Darshan / Varambally, Sooryanarayana et al. | 2023
- 602
-
ATP8B1: A prognostic prostate cancer biomarker identified via genetic analysisChen, Lih‐Chyang / Huang, Shu‐Pin / Shih, Chieh‐Tien / Li, Chia‐Yang / Chen, Yei‐Tsung / Huang, Chao‐Yuan / Yu, Chia‐Cheng / Lin, Victor C. / Lee, Cheng‐Hsueh / Geng, Jiun‐Hung et al. | 2023
- 612
-
Holmium laser enucleation of the prostate in men on active surveillance for prostate cancer with refractory lower urinary tract symptoms secondary to enlarged prostatesRam, Prasanna / Nayak, Prasant / Mandal, Swarnendu / Das, Manoj K. / Tripathy, Sambit et al. | 2023
- 613
-
The impact of genetic aberrations on response to radium‐223 treatment for castration‐resistant prostate cancer with bone metastasesRam, Prasanna / Mandal, Swarnendu / K. Das, Manoj / Nayak, Prasant et al. | 2023
- 614
-
CommentaryShahait, Mohammed / Mukherji, Deborah / Davicioni, Elai / Lee, David I. et al. | 2023